In summary, our study is the first to report that HMOX1 negatively regulates MMP-9 expression in CLL cells in response to ATO, through modulation of the p38 MAPK/AP-1 signaling pathway. Here, HMOX1 is linked to B-cell chronic lymphocytic leukemia.